Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Cohbar Inc (CWBR)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 199,562
  • Shares Outstanding, K 42,460
  • Annual Sales, $ 0 K
  • Annual Income, $ -9,830 K
  • 36-Month Beta 2.92
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 8.30

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.06 +7.14%
on 09/19/18
6.00 -27.50%
on 08/22/18
-1.29 (-22.87%)
since 08/21/18
3-Month
4.06 +7.14%
on 09/19/18
9.13 -52.33%
on 06/22/18
-5.00 (-53.48%)
since 06/21/18
52-Week
2.55 +70.59%
on 09/22/17
10.79 -59.68%
on 06/13/18
+1.65 (+61.11%)
since 09/21/17

Most Recent Stories

More News
CohBar Announces Second Quarter 2018 Financial Results

CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics (MBTs) to treat age-related diseases, today reported financial results for the second quarter...

CWBR : 4.35 (-7.45%)
Brain Ischemia Drug Development Pipeline Analysis Report 2018 - ResearchAndMarkets.com

The "2018 Brain Ischemia Drug Development Pipeline Analysis Report- Companies, Drugs, Clinical Trials, Latest Developments in Brain Ischemia Market" report has been added to ResearchAndMarkets.com's...

LIXT : 0.8500 (-4.49%)
CWBR : 4.35 (-7.45%)
CohBar Initiates Clinical Study with First-in-human Dosing of CB4211, a Novel Mitochondria Based Therapeutic for the Treatment of NASH

CohBar, Inc. (NASDAQ:CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics (MBTs) to treat age-related diseases, today announced that it has initiated a Phase 1a/1b safety...

CWBR : 4.35 (-7.45%)
CohBar Completes Sale of $20 Million Under Controlled Equity Offering

CohBar, Inc. (NASDAQ:CWBR), an innovative biotechnology company developing mitochondria based therapeutics (MBTs) to treat age-related diseases, today announced that it has completed sales of approximately...

CWBR : 4.35 (-7.45%)
CohBar Added to Russell 2000(R) Index

CohBar, Inc. (NASDAQ:CWBR), an innovative biotechnology company developing mitochondria based therapeutics (MBTs) to treat age-related diseases, was added to the US small-cap Russell 2000 Index during...

CWBR : 4.35 (-7.45%)
CohBar Presents Preclinical Data on Mechanism of Action for its Lead Candidate, CB4211, at American Diabetes Association 78th Scientific Sessions

CohBar, Inc. (NASDAQ:CWBR), an innovative biotechnology company focused on developing mitochondria based therapeutics (MBTs) to treat age-related diseases, today announced the presentation of preclinical...

CWBR : 4.35 (-7.45%)
CohBar, Inc. Announces First Quarter 2018 Financial Results

CohBar, Inc. (NASDAQ:CWBR) ("CohBar" or the "Company"), an innovative biotechnology company developing mitochondria based therapeutics (MBTs) to treat age-related diseases, today reported its financial...

CWBR : 4.35 (-7.45%)
CohBar, Inc. Announces Voluntary Delisting from the TSX Venture Exchange

CohBar, Inc. (NASDAQ:CWBR) and (TSXV:COB.U) ("CohBar" or the "Company") today announced that it has applied to voluntarily delist its common shares from the TSX Venture Exchange ("TSXV").

COB-U.VN : 5.000 (+4.17%)
CWBR : 4.35 (-7.45%)
CohBar, Inc. Announces Fourth Quarter 2017 Financial Results

CohBar, Inc. (NASDAQ:CWBR) (TSXV:COB.U) ("CohBar" or the "Company"), an innovative biotechnology company developing mitochondria based therapeutics (MBTs) to treat age-related diseases, today reported...

COB-U.VN : 5.000 (+4.17%)
CWBR : 4.35 (-7.45%)
CohBar, Inc. Announces Closing of First Tranche of Private Placement

CohBar, Inc. (NASDAQ:CWBR) (TSXV:COB.U) ("CohBar" or the "Company") is pleased to announce the closing of its first tranche of its previously announced private placement (the "Private Placement") offering...

COB-U.VN : 5.000 (+4.17%)
CWBR : 4.35 (-7.45%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

See More Share

Trade CWBR with:

Business Summary

Cohbar, Inc. operates is a biotechnology company. It engaged in the research and development of mitochondria-based therapeutics for the treatment of diseases associated with aging. Cohbar, Inc. is based in Menlo Park, California.

See More

Key Turning Points

2nd Resistance Point 4.88
1st Resistance Point 4.62
Last Price 4.35
1st Support Level 4.17
2nd Support Level 3.98

See More

52-Week High 10.79
Fibonacci 61.8% 7.64
Fibonacci 50% 6.67
Fibonacci 38.2% 5.70
Last Price 4.35
52-Week Low 2.55

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar